Thermaeye Plus Is a Safe and Effective Treatment for Ocular Rosacea
The new intense pulsed light treatment device, Thermaeye Plus, results in symptom and quality of life improvement in patients with meibomian gland dysfunction and blepharitis due to ocular rosacea, according to a study published in the European Journal of Dermatology.
Researchers performed a prospective, longitudinal study that evaluated a new intense pulsed light treatment device (Thermaeye Plus) for meibomian gland dysfunction and blepharitis due to ocular rosacea. A total of 74 eyes of 37 consecutive patients with ocular rosacea with a mean age of 45.6 ± 11.7 years were included in the study. Consecutive sessions that included 14 flashes with 10 J/cm2 on the periocular area and facial cheeks on Day 1, 14, 28, and 49 were conducted. Ocular Surface Disease Index (OSDI) and symptom score questionnaires, quality of live and facial severity degree, noninvasive tear meniscus height, noninvasive tear break up time, corneal fluorescein staining, and eyelid margin and meibomian gland assessment were used for clinical evaluation.
With Thermaeye Plus, a decrease in symptoms was shown with the OSDI questionnaire and 91.9% of patients achieved normal values. The symptom score questionnaire showed significant changes in dryness, foreign body sensation, light sensitivity, and pain. Most significant improvements were shown between baseline at Day 1 and 49. All eyelid signs improved, but it was most significant for telangiectasia/vascularity and blepharitis, resulting in a 78% clearance of facial rosacea. An 81.1% reduction of flushing was also demonstrated. All patients had improvement in quality of life after treatment.
“These results demonstrate that Thermaeye Plus is an effective and safe treatment for ocular rosacea,” concluded the study authors.
Reference
Vergés C, March de Ribot F, Salgado-Borges J, Gonzalez J. Prospective evaluation of intense pulsed light treatment for meibomian gland dysfunction and blepharitis due to ocular rosacea. Prospective evaluation of intense pulsed light treatment for meibomian gland dysfunction and blepharitis due to ocular rosacea. Eur J Dermatol. 2022;32(4):505-515. doi:10.1684/ejd.2022.4301
